NCT06769009 EUthyroid2: the Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europe
| NCT ID | NCT06769009 |
| Status | Recruiting |
| Phase | — |
| Sponsor | EUthyroid |
| Condition | Iodine Deficiency |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-11-18 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000 participants in total. It began in 2024-11-18 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In EUthyroid2 intervention measures are to be developed, implemented in ambulatory care settings and evaluated to effectively raise awareness for the risks of iodine deficiency among young women (18-24 years) in three European countries (Norway, Poland, UK) as well as Bangladesh and Pakistan. A cluster-randomized controlled trial with three points of measurements will be applied in each participating country. The intervention will be adapted to the different contextual characteristics of the implementation sites. A process evaluation with a convergent parallel mixed methods design will be conducted. For this, participants and healthcare professionals will be surveyed and semi-structured interviews will be carried out.
Eligibility Criteria
Inclusion Criteria: * non-pregnant Female * Age 18-24 years at the time point of recruitment * Attending the specified settings * Sufficient language skills to understand the study information, informed consent and the questionnaire Exclusion Criteria: * Having a thyroid disease * Pregnancy at the timepoint of recruitment and during the intervention period * Lactation
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06769009 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 24 Years, studying Iodine Deficiency. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06769009 currently recruiting?
Yes, NCT06769009 is actively recruiting participants. Contact the research team at euthyroid2@uni-greifswald.de for enrollment information.
Where is the NCT06769009 trial being conducted?
This trial is being conducted at Dhaka, Bangladesh, Bergen, Norway, Peshawar, Pakistan, Krakow, Poland and 2 additional locations.
Who is sponsoring the NCT06769009 clinical trial?
NCT06769009 is sponsored by EUthyroid. The trial plans to enroll 1,000 participants.